Utilization of Digoxin among Hospitalized Older Patients with Heart Failure and Atrial Fibrillation in Thailand: Prevalence, Associated Factors, and Clinical Outcomes

Background Digoxin is used to control heart rate in patients with heart failure (HF) and atrial fibrillation (AF). However, its use is often limited in older patients, as they are prone to digoxin toxicity. This study aimed to determine the prevalence of digoxin use, investigate the factors associat...

Full description

Bibliographic Details
Main Authors: Noppaket Singkham, Yuttana Wongsalap, Duangkamon Poolpun, Sirichok Phetnoo, Chuthalak Somkhon
Format: Article
Language:English
Published: Korea Geriatrics Society 2021-12-01
Series:Annals of Geriatric Medicine and Research
Subjects:
Online Access:http://www.e-agmr.org/upload/pdf/agmr-21-0098.pdf
_version_ 1818943432073150464
author Noppaket Singkham
Yuttana Wongsalap
Duangkamon Poolpun
Sirichok Phetnoo
Chuthalak Somkhon
author_facet Noppaket Singkham
Yuttana Wongsalap
Duangkamon Poolpun
Sirichok Phetnoo
Chuthalak Somkhon
author_sort Noppaket Singkham
collection DOAJ
description Background Digoxin is used to control heart rate in patients with heart failure (HF) and atrial fibrillation (AF). However, its use is often limited in older patients, as they are prone to digoxin toxicity. This study aimed to determine the prevalence of digoxin use, investigate the factors associated with digoxin use, and explore the association between digoxin use and clinical outcomes in older Thai patients with HF and AF. Methods This cross-sectional study used data obtained from an electronic medical records database. We performed logistic regression analysis to determine the prevalence of digoxin use at index discharge and the factors associated with its use. The Cox proportional hazard model was used to determine the association of all-cause mortality and HF rehospitalization with digoxin use. Results Of the 640 patients assessed, 107 (16.72%) were prescribed digoxin before discharge. The factors negatively associated with digoxin use included high serum creatinine level (adjusted odds ratio [AOR]=0.38; 95% confidence interval [CI], 0.22–0.65) and ischemic heart disease (IHD) (AOR=0.52; 95% CI, 0.30–0.88). The factors positively associated with digoxin use were the use of diuretics (AOR=2.65; 95% CI, 1.60–4.38) and mineralocorticoid receptor antagonists (MRAs) (AOR=2.24; 95% CI, 1.18–4.27). We observed no significant association between digoxin use and clinical outcomes (adjusted hazard ratio=1.00; 95% CI, 0.77–1.30). Conclusion Digoxin use was prevalent among older patients with HF and AF. Patients with high serum creatinine or IHD were less likely to be prescribed digoxin, whereas those using diuretics or MRAs were more likely to be prescribed digoxin. Although digoxin use was not uncommon among older patients, it was prescribed with caution among Thai patients hospitalized with HF and AF.
first_indexed 2024-12-20T07:27:14Z
format Article
id doaj.art-e6f0adc667cf4e9297135e775c87d924
institution Directory Open Access Journal
issn 2508-4798
2508-4909
language English
last_indexed 2024-12-20T07:27:14Z
publishDate 2021-12-01
publisher Korea Geriatrics Society
record_format Article
series Annals of Geriatric Medicine and Research
spelling doaj.art-e6f0adc667cf4e9297135e775c87d9242022-12-21T19:48:30ZengKorea Geriatrics SocietyAnnals of Geriatric Medicine and Research2508-47982508-49092021-12-0125426026810.4235/agmr.21.00981001Utilization of Digoxin among Hospitalized Older Patients with Heart Failure and Atrial Fibrillation in Thailand: Prevalence, Associated Factors, and Clinical OutcomesNoppaket Singkham0Yuttana Wongsalap1Duangkamon Poolpun2Sirichok Phetnoo3Chuthalak Somkhon4 Division of Pharmacy Practice, Department of Pharmaceutical Care, School of Pharmaceutical Sciences, University of Phayao, Phayao, Thailand Division of Pharmacy Practice, Department of Pharmaceutical Care, School of Pharmaceutical Sciences, University of Phayao, Phayao, Thailand Department of Pharmacy, Buddhachinaraj Hospital, Phitsanulok, Thailand Division of Pharmacy Practice, Department of Pharmaceutical Care, School of Pharmaceutical Sciences, University of Phayao, Phayao, Thailand Division of Pharmacy Practice, Department of Pharmaceutical Care, School of Pharmaceutical Sciences, University of Phayao, Phayao, ThailandBackground Digoxin is used to control heart rate in patients with heart failure (HF) and atrial fibrillation (AF). However, its use is often limited in older patients, as they are prone to digoxin toxicity. This study aimed to determine the prevalence of digoxin use, investigate the factors associated with digoxin use, and explore the association between digoxin use and clinical outcomes in older Thai patients with HF and AF. Methods This cross-sectional study used data obtained from an electronic medical records database. We performed logistic regression analysis to determine the prevalence of digoxin use at index discharge and the factors associated with its use. The Cox proportional hazard model was used to determine the association of all-cause mortality and HF rehospitalization with digoxin use. Results Of the 640 patients assessed, 107 (16.72%) were prescribed digoxin before discharge. The factors negatively associated with digoxin use included high serum creatinine level (adjusted odds ratio [AOR]=0.38; 95% confidence interval [CI], 0.22–0.65) and ischemic heart disease (IHD) (AOR=0.52; 95% CI, 0.30–0.88). The factors positively associated with digoxin use were the use of diuretics (AOR=2.65; 95% CI, 1.60–4.38) and mineralocorticoid receptor antagonists (MRAs) (AOR=2.24; 95% CI, 1.18–4.27). We observed no significant association between digoxin use and clinical outcomes (adjusted hazard ratio=1.00; 95% CI, 0.77–1.30). Conclusion Digoxin use was prevalent among older patients with HF and AF. Patients with high serum creatinine or IHD were less likely to be prescribed digoxin, whereas those using diuretics or MRAs were more likely to be prescribed digoxin. Although digoxin use was not uncommon among older patients, it was prescribed with caution among Thai patients hospitalized with HF and AF.http://www.e-agmr.org/upload/pdf/agmr-21-0098.pdffrail older adultsprevalencedrug utilizationdigoxinheart failureatrial fibrillation
spellingShingle Noppaket Singkham
Yuttana Wongsalap
Duangkamon Poolpun
Sirichok Phetnoo
Chuthalak Somkhon
Utilization of Digoxin among Hospitalized Older Patients with Heart Failure and Atrial Fibrillation in Thailand: Prevalence, Associated Factors, and Clinical Outcomes
Annals of Geriatric Medicine and Research
frail older adults
prevalence
drug utilization
digoxin
heart failure
atrial fibrillation
title Utilization of Digoxin among Hospitalized Older Patients with Heart Failure and Atrial Fibrillation in Thailand: Prevalence, Associated Factors, and Clinical Outcomes
title_full Utilization of Digoxin among Hospitalized Older Patients with Heart Failure and Atrial Fibrillation in Thailand: Prevalence, Associated Factors, and Clinical Outcomes
title_fullStr Utilization of Digoxin among Hospitalized Older Patients with Heart Failure and Atrial Fibrillation in Thailand: Prevalence, Associated Factors, and Clinical Outcomes
title_full_unstemmed Utilization of Digoxin among Hospitalized Older Patients with Heart Failure and Atrial Fibrillation in Thailand: Prevalence, Associated Factors, and Clinical Outcomes
title_short Utilization of Digoxin among Hospitalized Older Patients with Heart Failure and Atrial Fibrillation in Thailand: Prevalence, Associated Factors, and Clinical Outcomes
title_sort utilization of digoxin among hospitalized older patients with heart failure and atrial fibrillation in thailand prevalence associated factors and clinical outcomes
topic frail older adults
prevalence
drug utilization
digoxin
heart failure
atrial fibrillation
url http://www.e-agmr.org/upload/pdf/agmr-21-0098.pdf
work_keys_str_mv AT noppaketsingkham utilizationofdigoxinamonghospitalizedolderpatientswithheartfailureandatrialfibrillationinthailandprevalenceassociatedfactorsandclinicaloutcomes
AT yuttanawongsalap utilizationofdigoxinamonghospitalizedolderpatientswithheartfailureandatrialfibrillationinthailandprevalenceassociatedfactorsandclinicaloutcomes
AT duangkamonpoolpun utilizationofdigoxinamonghospitalizedolderpatientswithheartfailureandatrialfibrillationinthailandprevalenceassociatedfactorsandclinicaloutcomes
AT sirichokphetnoo utilizationofdigoxinamonghospitalizedolderpatientswithheartfailureandatrialfibrillationinthailandprevalenceassociatedfactorsandclinicaloutcomes
AT chuthalaksomkhon utilizationofdigoxinamonghospitalizedolderpatientswithheartfailureandatrialfibrillationinthailandprevalenceassociatedfactorsandclinicaloutcomes